Tag: Vaccines
FDA Head Says Any Approved COVID-19 Vaccine Will Be Safe
Assurance was given during a video briefing with the American Medical Association
Two-Thirds of U.S. Adults Likely to Get COVID-19 Vaccine
However, likelihood varies by geography, race, and other demographic factors
Flu Vaccination in High-Risk Groups May Reduce CV Events
Hospitalized patients at high risk who are vaccinated have lower rates of MI, TIA, cardiac arrest, death
Moderna Charging Much More for COVID-19 Vaccine Than Others
Vaccine currently in phase 3 trials; company confident it will be available by the end of the year
Johnson & Johnson Makes $1 Billion Vaccine Deal
Company has said it will offer doses at a not-for-profit cost to provide global access to the vaccine
Experimental COVID-19 Vaccine Shows Encouraging Results
One study revealed that 56 people made high levels of antibodies with no adverse side effects
U.S. Puts Up Another $2.1 Billion for Potential COVID-19 Vaccine
GlaxoSmithKline and Sanofi Pasteur will supply 100 million doses of its experimental vaccine to the U.S.
Plenty of COVID-19 Vaccine Coming, Fauci Says
To combat the surging pandemic, Fauci is calling on all Americans to practice social distancing and wearing masks
Teen HPV Vaccination Rates Suboptimal
Half of parents of unvaccinated teens have no intention to initiate the vaccine series
Nirsevimab Injection Cuts RSV-Linked Infections in Preemies
Maternal RSV fusion protein nanoparticle vaccine did not meet prespecified success criterion for efficacy
